Model of Allergic Bronchopulmonary Aspergillosis (ABPA) in Mice
Aspergillus is a common filamentus fungi and infection can result in three main types of bronchopulmonary aspergillosis; invasive aspergillosis, chronic aspergillosis, and allergic aspergillosis. Allergic
Mice are administered fungi suspended in agarose beads; a persistent fungal presence is observed for a minimum of 21 days after administration. Low level fungal presence and allergic responses are confirmed by measurable levels of BAL galactomannan and serum IgE respectively.
Image 1: Fungal Spores are embedded in agarose beads. Picture taken at magnification x 400
Image 2: Galactomannan (A biomarker of fungal infection, used in the clinic) is statistically significantly raised compared to the sham control group, confirming that there is an active fungal infection.
Study Design | |
---|---|
Species/Strain | C57BL/6J mouse |
Model | Allergic aspergillosis in mice |
Relevant Use | Efficacy of novel antifungals for ABPA |
Readouts Available | Daily Bodyweights and Clinical Signs, serum IgE, fungal load, BAL differential cell counts, BAL cytokines and Pathology (H&E and PAS) |
Study data generated by Labcorp Huntingdon Pharmacology.
Related Models
-
Bhas 42 Cell Transformation Assay (CTA)
Carcinogenicity, Discovery, Toxicology -
Asthma: Ovalbumin sensitization and challenge
Discovery -
Chlorine Induced Lung Injury
Discovery -
COPD: LPS + fMLP PK/PD model – Neutrophil Elastase Targets
Discovery -
COPD: Human Neutrophil Elastase Lung Hemorrhage Model
Discovery -
Bronchoconstriction models for LABA, LAMA & MABAs
Discovery -
Flu Model: H1N1 influenza lung infection model – viral COPD exacerbation
Discovery -
Model of Allergic Bronchopulmonary Aspergillosis (ABPA) in Mice
Discovery